The recent bankruptcy announcement of the genetic analysis company 23andMe, which facilitates DNA examination by allowing individuals to submit saliva samples, has opened up discussions on how such data might aid in solving long-standing cold cases.

“Having access to more extensive data can significantly assist law enforcement in cracking cold cases,” Eric Brown, who is the founder and CEO of Imperio Consulting, explained to Fox News Digital. “Previously inaccessible DNA data could become available to authorities, offering them genetic information they couldn’t access before.”

Historically, 23andMe has often declined to provide customer data to law enforcement unless presented with a valid court order or subpoena. According to the company’s Transparency Report, it has received a total of 15 law enforcement data requests but has not complied with any so far.

“The sale of 23andMe could increase the database by millions of records that they didn’t have access to before,” Brown said. “The least sliver of DNA from a criminal could 100% help law enforcement.” 

The rise and fall of 23andMe: Peak to plateau to panic

Eran Barak, CEO of MIND, a data security firm, told Fox News Digital that interest plateaued in DNA testing companies following their growth in the 2010s.

Barak said the companies’ downfall was due to market saturation, fewer consumers interested in recreational genealogy and rising consumer wariness about how their sensitive data is handled.

“When your DNA is compromised, it’s not just a password reset. It’s permanent,” he said.

“The breach raised alarm among customers concerned about their privacy and how DNA-testing firms handle their data,” Barak said. “Genetic data is arguably the most sensitive form of personally identifiable information (PII). It can reveal predispositions to disease, familial relationships and even be used in criminal investigations.”

The plateauing interest in recreational genealogy services moved many companies towards monetizing customer data through partnerships with pharmaceutical and research institutions. 

“The 23andMe bankruptcy isn’t just about business mismanagement or market downturns; it reflects growing skepticism around personal genetic data, rising concerns over PHI (Protected Health Information) and PII (Personally Identifiable Information) security, and broader shifts in how consumers engage with biotech and digital health platforms,” Barak said.

Fox News Digital has reached out to 23andMe for comment.

Fox News Digital’s Audrey Conklin contributed to this report.